Celldex Therapeutics, Inc. (CLDX) vs NewAmsterdam Pharma Company N.V. (NAMS)
- Celldex Therapeutics, Inc. CLDX 27.53 −4.84%
- NewAmsterdam Pharma Company N.V. NAMS 19.83 −3.83%
Celldex Therapeutics, Inc. and NewAmsterdam Pharma Company N.V. are both Biotechnology companies. Celldex Therapeutics, Inc. and NewAmsterdam Pharma Company N.V. are of similar size ($2.5B and $2.3B). Celldex Therapeutics, Inc. grew revenue faster over the last twelve months: −88.3% against −88.9%. NewAmsterdam Pharma Company N.V. has the higher net margin (−3,644.2% vs −33,883.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, NewAmsterdam Pharma Company N.V. leads on 11 and Celldex Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CLDX | NAMS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (36,733.82%) | (3,432.20%) | 0.00% |
| Net margin | (33,883.77%) | (3,644.21%) | 0.00% |
| Free cash flow margin | (27,294.81%) | (2,018.28%) | 0.00% |
| Return on equity | (43.88%) | (36.81%) | (56.36%) |
| Return on assets | (40.76%) | (34.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack